TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹9,392 Cr | ₹5,623 Cr | ₹5,611 Cr | ₹5,314 Cr | ₹5,165 Cr |
What is the latest Total Current Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹9,392 Cr |
| Mar2025 | ₹5,623 Cr |
| Mar2024 | ₹5,611 Cr |
| Mar2023 | ₹5,314 Cr |
| Mar2022 | ₹5,165 Cr |
How is Total Current Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,392 Cr | 67.04 | |
| Mar2025 | ₹5,623 Cr | 0.20 | |
| Mar2024 | ₹5,611 Cr | 5.60 | |
| Mar2023 | ₹5,314 Cr | 2.88 | |
| Mar2022 | ₹5,165 Cr | - | |
Compare Total Current Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹169,805.7 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹105,174.0 Cr | 0.6% | 7% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.5% |
11.3% |
49.6% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses